FCM
ZYME icon

Farallon Capital Management’s Zymeworks ZYME Stock Holding History

Farallon Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-400,000
Closed -$4.76M – 161
2025
Q1 		$4.76M Sell
400,000
-929,974
-70% -$12.7M 0.02% 81
2024
Q4 		$19.5M Sell
1,329,974
-31,026
-2% -$434K 0.09% 74
2024
Q3 		$17.1M Sell
1,361,000
-240,000
-15% -$2.61M 0.07% 78
2024
Q2 		$13.6M Hold
1,601,000
– – 0.06% 80
2024
Q1 		$16.8M Sell
1,601,000
-155,000
-9% -$1.72M 0.07% 80
2023
Q4 		$18.2M Sell
1,756,000
-244,000
-12% -$1.94M 0.08% 71
2023
Q3 		$12.7M Hold
2,000,000
– – 0.06% 80
2023
Q2 		$17.3M Hold
2,000,000
– – 0.09% 82
2023
Q1 		$18.1M Buy
2,000,000
+500,000
+33% +$4.36M 0.1% 84
2022
Q4 		$11.8M Buy
+1,500,000
New +$10.5M 0.07% 99
2021
Q2 		– Sell
-600,000
Closed -$18.9M – 312
2021
Q1 		$18.9M Sell
600,000
-150,000
-20% -$6.1M 0.09% 106
2020
Q4 		$35.4M Sell
750,000
-102,200
-12% -$4.75M 0.21% 77
2020
Q3 		$39.7M Buy
852,200
+302,200
+55% +$10.4M 0.27% 71
2020
Q2 		$19.8M Sell
550,000
-1,200,000
-69% -$44.2M 0.16% 88
2020
Q1 		$62.1M Buy
1,750,000
+50,000
+3% +$2.05M 0.53% 38
2019
Q4 		$77.3M Sell
1,700,000
-31,500
-2% -$1.14M 0.52% 43
2019
Q3 		$42.9M Sell
1,731,500
-24,970
-1% -$626K 0.32% 50
2019
Q2 		$38.6M Buy
1,756,470
+181,470
+12% +$3.33M 0.25% 61
2019
Q1 		$25.5M Hold
1,575,000
– – 0.19% 67
2018
Q4 		$23.1M Buy
1,575,000
+240,000
+18% +$3.15M 0.17% 64
2018
Q3 		$21M Buy
1,335,000
+580,000
+77% +$8.3M 0.12% 65
2018
Q2 		$11.2M Buy
+755,000
New +$11.7M 0.07% 76

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Farallon Capital Management's ZYME Position: Q2 2025 in Review

Farallon Capital Management sold out of Zymeworks (ZYME) in Q2 2025, closing a stake of 400,000 shares — an estimated $4.76M sold.

Farallon Capital Management first reported a position in ZYME in Q2 2018 and held it in 22 quarters. The position peaked at $77.3M in Q4 2019. 181 funds tracked by Wall St. Rank hold ZYME as of Q2 2025.

  • Farallon Capital Management reported no remaining Zymeworks position as of Q2 2025 after selling out during the quarter.
  • Farallon Capital Management sold 400,000 Zymeworks shares in Q2 2025, an estimated $4.76M.
  • Farallon Capital Management first reported a position in Zymeworks in Q2 2018 and held it in 22 quarters.
  • Farallon Capital Management's Zymeworks position peaked at $77.3M in Q4 2019.
  • 181 funds tracked by Wall St. Rank held Zymeworks as of Q2 2025.

Based on Farallon Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.